Your browser doesn't support javascript.
loading
Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor.
Wakamatsu, Sho; Jojima, Teruo; Hashiguchi, Masaaki; Kishi, Haruka; Niitani, Takafumi; Sakurai, Shintaro; Iijima, Toshie; Kogai, Takahiko; Tomaru, Takuya; Usui, Isao; Aso, Yoshimasa.
Afiliação
  • Wakamatsu S; Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan.
  • Jojima T; Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan. Electronic address: jojima@dokkyomed.ac.jp.
  • Hashiguchi M; Department of Cell Biology, Institute of Advanced Medical Sciences, Nippon Medical School, 1-1-5, Tokyo 113-8602, Japan.
  • Kishi H; Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan.
  • Niitani T; Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan.
  • Sakurai S; Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan.
  • Iijima T; Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan.
  • Kogai T; Department of Infection Control and Clinical Laboratory Medicine, Dokkyo Medical University, Tochigi 321-0293, Japan.
  • Tomaru T; Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan.
  • Usui I; Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan. Electronic address: isaousui@dokkyomed.ac.jp.
  • Aso Y; Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan.
J Diabetes Complications ; 38(1): 108650, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38035640
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Sorbitol / Carcinoma Hepatocelular / Diabetes Mellitus / Hepatopatia Gordurosa não Alcoólica / Inibidores do Transportador 2 de Sódio-Glicose / Neoplasias Hepáticas Limite: Animals Idioma: En Revista: J Diabetes Complications Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Sorbitol / Carcinoma Hepatocelular / Diabetes Mellitus / Hepatopatia Gordurosa não Alcoólica / Inibidores do Transportador 2 de Sódio-Glicose / Neoplasias Hepáticas Limite: Animals Idioma: En Revista: J Diabetes Complications Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão